Skip to main content
RMD
NYSE Life Sciences

ResMed Beats Q4, Issues FY27 Guidance, But Shares Sink 7% on Long-Term Worries

Tom Rudovsky · Reported by Market Index
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$212.5
Mkt Cap
$32.382B
52W Low
$180.265
52W High
$293.81
52W Position info
18% above low
Off High info
28% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

RMD sits 18% above its 52-week low of $180.265.

Summary

ResMed delivered a Q4 beat with revenue of $1.46B (in line) and EPS of $0.295 (2% above estimates), but shares fell 5.9% after hours as the market focused on FY27 guidance and long-term threats. The company issued its first-ever revenue outlook, guiding to 5-7% underlying revenue growth and 12-14% earnings growth, while boosting shareholder returns to over $1.85B. However, the outlook failed to address the looming re-entry of Philips into the US market in 2027, a key investor concern. The Astral ventilator recall will create a $75M revenue headwind and $0.15 EPS drag, though this was already priced into guidance. The sell-off reflects persistent anxiety over GLP-1 drugs and competitive risks, overshadowing solid near-term execution and a 10% dividend hike.

At the time of this announcement, RMD was trading at $212.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $32.4B. The 52-week trading range was $180.27 to $293.81. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Market Index.


Price Chart

Share this article

Copied!

RMD - Latest Insights

RMD
Oct 29, 2026, 6:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $253.00
Real-time Price: $238.53 info
Change: -$14.47 (-6%) info
Market Cap: $33.551B info
RMD
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $252.83
Real-time Price: $238.53 info
Change: -$14.30 (-6%) info
Market Cap: $33.551B info
RMD
Sep 01, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $231.75
Real-time Price: $238.53 info
Change: +$6.78 (+3%) info
Market Cap: $33.551B info
RMD
Sep 01, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $231.36
Real-time Price: $238.53 info
Change: +$7.17 (+3%) info
Market Cap: $33.551B info
RMD
Aug 17, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $220.37
Real-time Price: $238.53 info
Change: +$18.16 (+8%) info
Market Cap: $33.551B info